5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane

C175H353N23 — CID 159230799

IUPAC5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane
SMILESCC(C)(C)C1CCN(C2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)C1CN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)CC1CN(C(C)(C)C)C1.CC(C)(C)CCCCN1CCN(C(C)(C)C)CC1.CC(C)(C)CN1CC2(CCCN(C(C)(C)C)C2)C1.CC(C)(C)CN1CCC2CN(C(C)(C)C)CCC2C1.CC(C)(C)N1CC(CN2CC3CN(C(C)(C)C)CC3C2)C1.CC(C)(C)N1CCC2(CC1)CCN(C(C)(C)C)CC2.CC(C)(C)N1CCC2(CC1)CN(C(C)(C)C)C2.CC(C)(C)N1CCCC2(C1)CN(C(C)(C)C)C2.CC(C)(C)N1CCN(CC2CN(C(C)(C)C)C2)CC1
InChIInChI=1S/C18H35N3.C18H36N2.2C17H34N2.C16H33N3.C16H32N2.C16H34N2.3C15H30N2.C12H25N/c1-17(2,3)20-8-14(9-20)7-19-10-15-12-21(18(4,5)6)13-16(15)11-19;1-17(2,3)15-7-11-19(12-8-15)16-9-13-20(14-10-16)18(4,5)6;1-15(2,3)18-11-7-17(8-12-18)9-13-19(14-10-17)16(4,5)6;1-16(2,3)13-18-9-7-15-12-19(17(4,5)6)10-8-14(15)11-18;1-15(2,3)18-9-7-17(8-10-18)11-14-12-19(13-14)16(4,5)6;1-14(2,3)10-17-11-16(12-17)8-7-9-18(13-16)15(4,5)6;1-15(2,3)9-7-8-10-17-11-13-18(14-12-17)16(4,5)6;1-14(2,3)13-10-16(11-13)7-12-8-17(9-12)15(4,5)6;1-13(2,3)16-9-7-15(8-10-16)11-17(12-15)14(4,5)6;1-13(2,3)16-9-7-8-15(10-16)11-17(12-15)14(4,5)6;1-11(2,3)7-10-8-13(9-10)12(4,5)6/h14-16H,7-13H2,1-6H3;15-16H,7-14H2,1-6H3;7-14H2,1-6H3;14-15H,7-13H2,1-6H3;14H,7-13H2,1-6H3;7-13H2,1-6H3;7-14H2,1-6H3;12-13H,7-11H2,1-6H3;2*7-12H2,1-6H3;10H,7-9H2,1-6H3
InChIKeyKSWGLQAFCBFYJK-UHFFFAOYSA-N
MW2779.91 g/mol
LogP34.41
Rot. Bonds14

About 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane

5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane (PubChem CID 159230799) has the molecular formula C175H353N23 and a molecular weight of 2779.91 g/mol. Its IUPAC name is 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane.

Molecular Properties

Compound Name5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane
PubChem CID159230799
Molecular FormulaC175H353N23
Molecular Weight2779.91 g/mol
Exact Mass2777.83
IUPAC Name5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane
SMILESCC(C)(C)C1CCN(C2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)C1CN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)CC1CN(C(C)(C)C)C1.CC(C)(C)CCCCN1CCN(C(C)(C)C)CC1.CC(C)(C)CN1CC2(CCCN(C(C)(C)C)C2)C1.CC(C)(C)CN1CCC2CN(C(C)(C)C)CCC2C1.CC(C)(C)N1CC(CN2CC3CN(C(C)(C)C)CC3C2)C1.CC(C)(C)N1CCC2(CC1)CCN(C(C)(C)C)CC2.CC(C)(C)N1CCC2(CC1)CN(C(C)(C)C)C2.CC(C)(C)N1CCCC2(C1)CN(C(C)(C)C)C2.CC(C)(C)N1CCN(CC2CN(C(C)(C)C)C2)CC1
InChIInChI=1S/C18H35N3.C18H36N2.2C17H34N2.C16H33N3.C16H32N2.C16H34N2.3C15H30N2.C12H25N/c1-17(2,3)20-8-14(9-20)7-19-10-15-12-21(18(4,5)6)13-16(15)11-19;1-17(2,3)15-7-11-19(12-8-15)16-9-13-20(14-10-16)18(4,5)6;1-15(2,3)18-11-7-17(8-12-18)9-13-19(14-10-17)16(4,5)6;1-16(2,3)13-18-9-7-15-12-19(17(4,5)6)10-8-14(15)11-18;1-15(2,3)18-9-7-17(8-10-18)11-14-12-19(13-14)16(4,5)6;1-14(2,3)10-17-11-16(12-17)8-7-9-18(13-16)15(4,5)6;1-15(2,3)9-7-8-10-17-11-13-18(14-12-17)16(4,5)6;1-14(2,3)13-10-16(11-13)7-12-8-17(9-12)15(4,5)6;1-13(2,3)16-9-7-15(8-10-16)11-17(12-15)14(4,5)6;1-13(2,3)16-9-7-8-15(10-16)11-17(12-15)14(4,5)6;1-11(2,3)7-10-8-13(9-10)12(4,5)6/h14-16H,7-13H2,1-6H3;15-16H,7-14H2,1-6H3;7-14H2,1-6H3;14-15H,7-13H2,1-6H3;14H,7-13H2,1-6H3;7-13H2,1-6H3;7-14H2,1-6H3;12-13H,7-11H2,1-6H3;2*7-12H2,1-6H3;10H,7-9H2,1-6H3
InChIKeyKSWGLQAFCBFYJK-UHFFFAOYSA-N
XLogP34.41
TPSA74.52 Ų
H-Bond Donors
H-Bond Acceptors23
Rotatable Bonds14
Heavy Atoms198
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002779.91
LogP ≤ 534.41
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane?
The IUPAC name of 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane (CID 159230799) is 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane.
What is the SMILES notation for 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane?
The canonical SMILES for 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane is CC(C)(C)C1CCN(C2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)C1CN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)CC1CN(C(C)(C)C)C1.CC(C)(C)CCCCN1CCN(C(C)(C)C)CC1.CC(C)(C)CN1CC2(CCCN(C(C)(C)C)C2)C1.CC(C)(C)CN1CCC2CN(C(C)(C)C)CCC2C1.CC(C)(C)N1CC(CN2CC3CN(C(C)(C)C)CC3C2)C1.CC(C)(C)N1CCC2(CC1)CCN(C(C)(C)C)CC2.CC(C)(C)N1CCC2(CC1)CN(C(C)(C)C)C2.CC(C)(C)N1CCCC2(C1)CN(C(C)(C)C)C2.CC(C)(C)N1CCN(CC2CN(C(C)(C)C)C2)CC1.
What is the InChIKey of 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane?
The InChIKey is KSWGLQAFCBFYJK-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H35N3.C18H36N2.2C17H34N2.C16H33N3.C16H32N2.C16H34N2.3C15H30N2.C12H25N/c1-17(2,3)20-8-14(9-20)7-19-10-15-12-21(18(4,5)6)13-16(15)11-19;1-17(2,3)15-7-11-19(12-8-15)16-9-13-20(14-10-16)18(4,5)6;1-15(2,3)18-11-7-17(8-12-18)9-13-19(14-10-17)16(4,5)6;1-16(2,3)13-18-9-7-15-12-19(17(4,5)6)10-8-14(15)11-18;1-15(2,3)18-9-7-17(8-10-18)11-14-12-19(13-14)16(4,5)6;1-14(2,3)10-17-11-16(12-17)8-7-9-18(13-16)15(4,5)6;1-15(2,3)9-7-8-10-17-11-13-18(14-12-17)16(4,5)6;1-14(2,3)13-10-16(11-13)7-12-8-17(9-12)15(4,5)6;1-13(2,3)16-9-7-15(8-10-16)11-17(12-15)14(4,5)6;1-13(2,3)16-9-7-8-15(10-16)11-17(12-15)14(4,5)6;1-11(2,3)7-10-8-13(9-10)12(4,5)6/h14-16H,7-13H2,1-6H3;15-16H,7-14H2,1-6H3;7-14H2,1-6H3;14-15H,7-13H2,1-6H3;14H,7-13H2,1-6H3;7-13H2,1-6H3;7-14H2,1-6H3;12-13H,7-11H2,1-6H3;2*7-12H2,1-6H3;10H,7-9H2,1-6H3.
What are the key properties of 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane?
5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane has a molecular weight of 2779.91 g/mol, XLogP of 34.41, 14 rotatable bonds, 0 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 5-tert-butyl-2-[(1-tert-butylazetidin-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-3-[(3-tert-butylazetidin-1-yl)methyl]azetidine;1-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine;1-tert-butyl-4-(4-tert-butylpiperidin-1-yl)piperidine;1-tert-butyl-4-(5,5-dimethylhexyl)piperazine;2-tert-butyl-6-(2,2-dimethylpropyl)-1,3,4,4a,5,7,8,8a-octahydro-2,6-naphthyridine;1-tert-butyl-3-(2,2-dimethylpropyl)azetidine;8-tert-butyl-2-(2,2-dimethylpropyl)-2,8-diazaspiro[3.5]nonane;2,7-ditert-butyl-2,7-diazaspiro[3.5]nonane;2,8-ditert-butyl-2,8-diazaspiro[3.5]nonane;3,9-ditert-butyl-3,9-diazaspiro[5.5]undecane is sourced from PubChem (CID 159230799), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).